Eruptive squamous cell carcinoma in a patient receiving abatacept for rheumatoid arthritis

J Am Acad Dermatol. 2013 Oct;69(4):e178-9. doi: 10.1016/j.jaad.2013.04.018.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Abatacept
  • Arthritis, Rheumatoid / diagnosis
  • Arthritis, Rheumatoid / drug therapy*
  • Biopsy, Needle
  • Carcinoma, Squamous Cell / chemically induced*
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / surgery
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoconjugates / adverse effects*
  • Immunoconjugates / therapeutic use
  • Immunohistochemistry
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use
  • Injections, Intravenous
  • Keratosis, Actinic / chemically induced*
  • Keratosis, Actinic / pathology
  • Keratosis, Actinic / surgery
  • Middle Aged
  • Risk Assessment
  • Skin Neoplasms / chemically induced*
  • Skin Neoplasms / pathology
  • Skin Neoplasms / surgery

Substances

  • Immunoconjugates
  • Immunosuppressive Agents
  • Abatacept